Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023 : vimarsana.com

Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023

Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023

forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Radnor , Pennsylvania , United States , Philadelphia , American , Tanabe Pharma , David Rodman , Tom Weible , Curropin Nephrol Hypertens , Catalys Pacific , Twitter , Drug Administration , Exchange Commission , Linkedin , Nasdaq , Journal Of The American Medical Association , Elixir Health Public Relations , American Heart Association , Mineralys Therapeutics Inc , Mineralys Therapeutics , Scientific Sessions , Chief Medical Officer , American Medical Association , Aldosterone Dependent Hypertension , Targeted Approach , Uncontrolled Hypertension , United States Food , Mitsubishi Tanabe Pharma , Private Securities Litigation Reform Act , Opin Nephrol ,